Produkty 195723-38-7

CAS 195723-38-7 występuje w naszej ofercie pod nazwami: 2,16,19-Kauranetriol 2-o-beta-D-allopyranoside, 2,16,19-Kauranetriol 2-O-β-D-allopyranoside. Oferty producentów: Biosynth, MedChemExpress. Dostępne opakowania: 10mg, 5mg, 25mg, 50mg, Get quote.

2,16,19-Kauranetriol 2-o-beta-D-allopyranoside
Biosynth
  • opakowanie: 10mg, 5mg, 25mg, 50mg
  • Warianty: 4
Zobacz produkt
2,16,19-Kauranetriol 2-O-β-D-allopyranoside
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R,3R,4R,5S,6R)-2-[[(1S,4S,5R,7S,9S,10R,13R,14R)-14-hydroxy-5-(hydroxymethyl)-5,9,14-trimethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol (CAS 195723-38-7) to związek chemiczny o wzorze sumarycznym C26H44O8 i masie molowej 484.6 g/mol. Nazwa systematyczna IUPAC: (2R,3R,4R,5S,6R)-2-[[(1S,4S,5R,7S,9S,10R,13R,14R)-14-hydroxy-5-(hydroxymethyl)-5,9,14-trimethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol. InChIKey: QCOICVPTIKZOPU-YCROVFPPSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H44O8
Masa molowa484.6 g/mol
Nazwa IUPAC(2R,3R,4R,5S,6R)-2-[[(1S,4S,5R,7S,9S,10R,13R,14R)-14-hydroxy-5-(hydroxymethyl)-5,9,14-trimethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
InChIKeyQCOICVPTIKZOPU-YCROVFPPSA-N
SMILESC[C@]1(C[C@H](C[C@@]2([C@@H]1CC[C@]34[C@H]2CC[C@H](C3)[C@](C4)(C)O)C)O[C@H]5[C@@H]([C@@H]([C@@H]([C@H](O5)CO)O)O)O)CO

Dane obliczone przez PubChem (NCBI)

Synonimy: 2,16,19-Kauranetriol 2-O-beta-D-allopyranoside, 2,16,19-Kauranetriol 2-O-beta-D-Allopyranosid, 2,16,19-Kauranetriol 2-O-|A-D-allopyranoside, 2,16,19-Kauranetriol 2-O-beta-D-allopyraside, orb1683848, 2,16,19-Kauranetriol 2-O-|?-D-allopyranoside, beta-D-Allopyranoside,(2,4)-16,18-dihydroxykauran-2-yl, |?-D-Allopyranoside, (2|?,4| cent)-16,18-dihydroxykauran-2-yl
Izomery (ten sam wzór sumaryczny)
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid C26H44O8
(2R,3R,4S,5S,6R)-2-[[(2R,4aS,4bR,7S,10aS)-7-[(1R)-1,2-dihydroxyethyl]-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthren-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
2-[(E)-5-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
2-[(6,14-dihydroxy-5,5,9-trimethyl-14-tetracyclo[11.2.1.01,10.04,9]hexadecanyl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
(2R,3R,4S,5S,6R)-2-[[(1R,4aS,5R,8aS)-5-[(Z)-5-hydroxy-3-(hydroxymethyl)pent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
(2R,3R,4S,5S,6R)-2-[[(1R,3R,4R,7R,9S,10R,13R,14R)-3,14-dihydroxy-5,5,9,14-tetramethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8
(2R,3R,4R,5S,6R)-2-[[(1R,3R,4R,7R,9S,10R,13R,14R)-3,14-dihydroxy-5,5,9,14-tetramethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H44O8